Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 17, 2024VaccineOpen Access

Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSue Ann Costa ClemensUniversity of SienaLWLily Yin WeckxUniversidade Federal de São PauloEMEveline Pı́polo MilanUniversidade Federal do Rio Grande do Norte

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Clemens et al. (2024) studied this question.

synapsesocial.com/papers/68e6999bb6db64358761f339https://doi.org/10.1016/j.vaccine.2024.05.009
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study2021 · 687 citations
  2. 2XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.12024 · 184 citations
  3. 3Hybrid immunity2021 · 308 citations
  4. 4Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods2023 · 85 citations
  5. 5Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults2022 · 239 citations